141 related articles for article (PubMed ID: 10430321)
1. Tumor angiogenesis in gallbladder carcinoma.
Sugawara Y; Makuuchi M; Harihara Y; Noie T; Inoue K; Kubota K; Takayama T
Hepatogastroenterology; 1999; 46(27):1682-6. PubMed ID: 10430321
[TBL] [Abstract][Full Text] [Related]
2. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.
Jaeger TM; Weidner N; Chew K; Moore DH; Kerschmann RL; Waldman FM; Carroll PR
J Urol; 1995 Jul; 154(1):69-71. PubMed ID: 7539869
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
Siitonen SM; Haapasalo HK; Rantala IS; Helin HJ; Isola JJ
Mod Pathol; 1995 Sep; 8(7):745-52. PubMed ID: 8539232
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of angiogenesis by Chalkley counting in gallbladder carcinoma.
da Rocha AO; Coutinho LM; Schall JG
Hepatogastroenterology; 2009; 56(89):34-8. PubMed ID: 19453024
[TBL] [Abstract][Full Text] [Related]
6. Microvessel density is a prognostic indicator for patients with astroglial brain tumors.
Leon SP; Folkerth RD; Black PM
Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246
[TBL] [Abstract][Full Text] [Related]
7. Endothelial area as a prognostic indicator for invasive breast carcinoma.
Simpson JF; Ahn C; Battifora H; Esteban JM
Cancer; 1996 May; 77(10):2077-85. PubMed ID: 8640673
[TBL] [Abstract][Full Text] [Related]
8. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Weidner N; Carroll PR; Flax J; Blumenfeld W; Folkman J
Am J Pathol; 1993 Aug; 143(2):401-9. PubMed ID: 7688183
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer.
Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J
Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188
[TBL] [Abstract][Full Text] [Related]
10. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
[TBL] [Abstract][Full Text] [Related]
11. Tumor angiogenesis in advanced stage ovarian carcinoma.
Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
[TBL] [Abstract][Full Text] [Related]
12. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
[TBL] [Abstract][Full Text] [Related]
13. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.
Nakashima T; Kondoh S; Kitoh H; Ozawa H; Okita S; Harada T; Shiraishi K; Ryozawa S; Okita K
Int J Mol Med; 2003 Jan; 11(1):33-9. PubMed ID: 12469214
[TBL] [Abstract][Full Text] [Related]
15. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
18. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]